Empowering RMD Patients Through Education: The Role of Patient Organizations

Patient organizations play a crucial role in educating and supporting individuals with rheumatic musculoskeletal diseases, offering resources on disease management and addressing sensitive topics like sexual health.
Receiving a diagnosis of a rheumatic musculoskeletal disease (RMD) can be overwhelming for patients, who often require extensive information about their condition. Different individuals have varying preferences for how they receive this information—some may want comprehensive details immediately, while others prefer smaller, manageable portions spread over time. This diversity can challenge healthcare professionals, including rheumatologists, in delivering effective patient education.
At the 2025 European Congress of Rheumatology (EULAR), two impactful projects highlighted how patient organizations can facilitate better education and support for people with RMDs. One project introduced the concept of "introduction maps," developed through collaboration between patient experts and healthcare providers from ReumaNet in Belgium. These maps serve as high-quality, easily updatable resources that guide patients to various educational materials, including brochures, consultation tips, self-management strategies, and contact information for relevant services and organizations. Different versions of these maps have been created for diseases such as rheumatoid arthritis, spondyloarthritis, juvenile idiopathic arthritis, psoriatic arthritis, systemic lupus erythematosus, systemic sclerosis, vasculitis, myositis, Sjögren's disease, fibromyalgia, osteoporosis, and RMDs in general. Since their launch in September 2024, over 1,000 maps have been distributed, with plans to translate them into other languages to broaden their reach.
Another significant initiative focuses on raising awareness about a often-overlooked aspect of RMDs: sexual dysfunction. Studies indicate that a considerable percentage of patients with conditions like rheumatoid arthritis (67%) and systemic lupus erythematosus (60%) experience sexual health issues, yet discussing these topics remains stigmatized. The Norwegian Rheumatism Association, in collaboration with a certified sexologist, launched a campaign leveraging digital platforms and community outreach to educate, raise awareness, and encourage patients to seek help. The campaign includes social media efforts, articles in patient magazines reaching thousands, and peer support programs, all aimed at breaking social taboos and providing reliable information.
These examples demonstrate how patient organizations are vital in creating accessible, relevant, and personalized educational resources that meet diverse patient needs. By supporting information dissemination and fostering open dialogues about sensitive issues, they empower individuals living with RMDs to take control of their health and well-being.
Source: https://medicalxpress.com/news/2025-06-patient-rmd-patients.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Supreme Court Declines to Hear Case Against Anti-Vaccine Group Over Free Speech Rights
The U.S. Supreme Court has declined to review a case claiming social media censorship of anti-vaccine content, reinforcing private platform rights. Learn more about the legal and free speech implications.
Early Childhood Years: A Crucial Period to Prevent Overweight and Obesity
Early childhood is a critical period for preventing obesity later in life. New research highlights the importance of monitoring BMI during the first five years to intervene effectively and promote lifelong health.
The Importance of Numerical Communication in Medical Risk Assessment
Effective medical risk communication involves using clear, scientific numbers to help patients accurately understand health threats, improving decision-making and trust.
Innovative 3D Microphysiological Model Highlights Pericyte-Driven Chemoresistance in Glioblastoma
A new 3D biomimetic model developed by researchers at TIBI demonstrates how pericytes contribute to drug resistance in glioblastoma, offering a powerful tool for therapy discovery and personalized medicine.